China's drug regulator granted Hunan Warrant Pharmaceutical (SHA:688799) subsidiary Hunan Warrant Pharmaceutical Chiral marketing approval for its fluorescein sodium chemical raw material.
The chemical is used as dye for diagnostic fundus angiography and iris vascular fluorescein angiography for eye exams, according to a Wednesday filing with the Shanghai bourse.